
Semax
ACTH(4-10) Synthetic Analogue
Semax is a synthetic peptide analogue of ACTH(4-10) developed in Russia for cognitive enhancement and neuroprotection. It enhances BDNF expression, promotes neuroplasticity, and improves memory, attention, and cognitive processing speed while providing neuroprotective benefits against ischemic damage.
Clinical Benefits
Mechanism of Action
Semax acts as a synthetic ACTH(4-10) analogue that crosses the blood-brain barrier via intranasal administration. It enhances BDNF and NGF expression, promotes neuroplasticity through activation of neurotrophin signaling pathways, and modulates dopaminergic and serotonergic neurotransmission to improve cognitive function and provide neuroprotection.
Proven Results
Medical Disclaimer
Semax is a research chemical not approved by the FDA for human use in the United States. It is approved for medical use in Russia. All information is for educational purposes only. Consult with a qualified healthcare provider familiar with peptide therapy before considering use. Individual results may vary, and proper medical supervision is recommended for optimal safety and effectiveness.